| Literature DB >> 27903018 |
Robertas Kvascevicius1, Ona Lapteva1, Jurate Kesiene2, Alfredas Vaitkus3, Laima Mikulenaite4, Ramunas Raugalas5, Jurate Sipylaite3, Saulius Rocka1, Alvydas Juocevicius2.
Abstract
Spasticity of cerebral or spinal origin severely impairs an individual's functional ability and quality of life. Intrathecal baclofen (ITB) therapy via an implantable pump is indicated for use in patients unresponsive to oral antispasmodics. ITB therapy improves the daily caring for and relief of painful spasms. In Lithuania, ITB therapy was introduced in clinical practice just recently. We share our experience of spasticity management with the ITB pump system in five patients at Vilnius University Hospital Santariskiu Klinikos. Four patients had spastic tetraplegia associated with cerebral palsy, and one patient developed spastic paraplegia after a spinal epidural abscess. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27903018 DOI: 10.1055/s-0036-1593973
Source DB: PubMed Journal: J Neurol Surg A Cent Eur Neurosurg ISSN: 2193-6315 Impact factor: 1.268